CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Managing Data in Digital Clinical Trials

Managing Data in Digital Clinical...

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

Israel-Based Clearmind Medicine...

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Offers Clinical Trial...

Outsourcing the Potential Laboratory Services To Ensure Maximum Efficacy of Trials

Outsourcing the Potential Laboratory...

Boosting Clinical Cooperation for Improved Efficacy of Clinical Trials

Boosting Clinical Cooperation for...

Clinical Trials Climate in EU to Upsurge in the Future

Clinical Trials Climate in EU to...

Top Clinical Lab Equipment and Supply Chain Trends to Watch out for in 2022

Top Clinical Lab Equipment and Supply...

Common Challenges Hampering Clinical Laboratory Services

Common Challenges Hampering Clinical...

Managing Data in Digital Clinical Trials

Managing Data in Digital Clinical...

Israel-Based Clearmind Medicine Offers First Clinical Center for Alcohol Use Disorder Trial

Israel-Based Clearmind Medicine...

Adagene Offers Clinical Trial Collaboration to Evaluate Roche's Standard-of-Care for First-Line Advanced Liver Cancer

Adagene Offers Clinical Trial...

Outsourcing the Potential Laboratory Services To Ensure Maximum Efficacy of Trials

Outsourcing the Potential Laboratory...

Boosting Clinical Cooperation for Improved Efficacy of Clinical Trials

Boosting Clinical Cooperation for...

Clinical Trials Climate in EU to Upsurge in the Future

Clinical Trials Climate in EU to...

Top Clinical Lab Equipment and Supply Chain Trends to Watch out for in 2022

Top Clinical Lab Equipment and Supply...

Common Challenges Hampering Clinical Laboratory Services

Common Challenges Hampering Clinical...

Accessing Sensitive Research Data Via European Genome-Phenome Archive(EGA)

Life Sciences Review | Monday, September 26, 2022
Tweet

The European Genome-Phenome Archive enables the sharing and processing of sensitive information all across the EU.


FREMONT, CA: A network is anticipated to be established by research organisations to share sensitive health data all across the globe. As a pilot measure in accessing federated networks for the sharing of genomic data, the European Genome-Phenome Archive(EGA) is processing the collaboration agreements with national nodes. Additionally, the federated EGA aims at sponsoring data reuse, reproducibility, acceleration of biomedical research, and improved medical health via secure and efficient management of human omics data.


Generated by research initiatives, the sensitive human omics data are facilitated via specialist repositories, enabling services for data submission, access, and recovery. One testament to this repository measure is EGA, which is jointly managed by the European Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI) and the Genomic Regulation Centre. Countries in the realm are introducing personalised medicine programmes to generate data from national initiatives and promote a transition in human genomics to shift from a research-driven to a research-funding space through healthcare. However, the clinical context-generated data are more highly confidential than typical research data and hence require prioritised governance that is agreeable with the national data protection legislation.


Generally, a federated EGA facilitates a network of connected sources for the transnational discovery and access of human omic data besides heeding jurisdictional data protection and regulations to overcome the hurdles in the sector. In the due course, its infrastructure enables supporting the European initiatives goals’ like the 1+ Million Genomes initiative (1+MG), the European Data Space, and an increased number of EU-funded 1+MG implementation projects that encompasses Beyond 1 Million Genomes.


The approach aims at processing global discoveries within its network per structure nodes, which are typically funded and operated. Several transnational and national initiatives and multiple parallel efforts provide the technical and legal frameworks for the effective establishment of a Federated EGA. Hence, five nodes—Finland, Germany, Norway, Spain, and Sweden—signed the collaboration agreements and were appointed as members of the EGA.


Finland-based IT Centres for Science facilitates data management services relying on the national laws and requirements of the EU's General Data Protection Regulation(GDPR). They provide sensitive research data with tools and support from collection to analysis, publication, and authorised re-use. Meanwhile, the German-based Genome-Phenome services bestow an ethical and legal framework in addition to the national infrastructure for an adequate balance in Omic data usage and data protection. Similarly, Norway holds the Sensitive Data Service (TSD) as the key component of its infrastructure. Spain often stores sensitive biomedical data via national services. Meanwhile, Sweden utilises a secure data archive platform to handle sensitive datasets.


Hence, a federated European Genome-Phenome Archive enables in accessing human omics data, concerning their health and thus favours consistency in clinical trials.   


Weekly Brief

loading

  • Top 10 Clinical Trial Services Companies - 2022
  • Top 10 Emerging Clinical Trial Management Companies - 2022
  • Top 10 Clinical Trial Management System Companies - 2022
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Antibodies: Immunoglobulin Isotypes

Life Science Consulting Services Trends

Rani Therapeutics and Celltrion Partner to Develop Oral Monoclonal Antibodies

ProPhase Labs Acquires BE-Smart Esophageal Pre-Cancer Screening Test

The Influence of Pharmaceutical Distributors on U.S. Drug Expenditures

Tips to Improve Medical Writing

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/accessing-sensitive-research-data-via-european-genomephenome-archiveega-nwid-982.html